PORT WASHINGTON, N.Y.--(BUSINESS WIRE)--Pall Corporation (NYSE: PLL), a global leader in filtration, separation and purification, today announced the launch of the Leukotrap® Affinity Plus Prion and Leukocyte Reduction Filter System. The new blood filter reduces prions and leukocytes in a single step. The Leukotrap® Affinity Plus System is CE marked in accordance with requirements set out in the Medical Devices Directive (93/42/EEC).
